Roivant Corp (ROIV) - Koefisien utang jangka dawa marang modal

Roivant Sciences Ltd. (ROIV) operates as a biotech incubator that acquires valuable developments to accelerate their time-to-market, although global instability and sanctions are currently hindering international logistics and testing. The market trend for the share price reflects the indicator 0.02. High shareholder confidence is driven by Matt Glynn's team, which possesses the expertise to skillfully scale and profitably divest subsidiary structures.

This metric determines the ratio of liabilities with a maturity of over one year to equity, measuring the business's degree of financial autonomy from long-term creditors. By analyzing the long-term debt-to-equity ratio, an investor assesses the stability of Roivant Sciences Ltd. (ROIV), whose viability depends on FDA approvals and research results rather than market cyclicality or seasonal demand fluctuations.